Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02104921 · ClinicalTrials.gov registry record
Innovative Ultrasound Technology in Neuromuscular Disease
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 223
- Enrollment target
NCT02104921 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 223 participants.
The verdict
NCT02104921 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 223 participants
- Enrollment target
Study Summary
This study is utilizing ultrasound measurement to measure neuromuscular disease status in adult patients. The hypothesis is the by quantifying ultrasound data, it is possible that ultrasound can be utilized as a tool to determine if a disease is responding to therapy or progressing.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2013-12-01 |
| Est. Completion | 2020-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02104921
The ClinicalTrials.gov registry entry for NCT02104921 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02104921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02104921 about?
NCT02104921 is a clinical study titled "Innovative Ultrasound Technology in Neuromuscular Disease". This study is utilizing ultrasound measurement to measure neuromuscular disease status in adult patients. The hypothesis is the by quantifying ultrasound data, it is possible that ultrasound can be utilized as a tool to determine if a disease is responding to therapy or progressing.
What is the current status of trial NCT02104921?
This trial is currently completed. The enrollment target is 223 participants. The study started on 2013-12-01. Estimated completion is 2020-03-01.
Who is sponsoring clinical trial NCT02104921?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.